BioCryst Pharmaceuticals
BCRX
#5074
Rank
$1.59 B
Marketcap
$7.59
Share price
-0.65%
Change (1 day)
-1.81%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Net assets

Net assets on the balance sheet as of September 2025 : -$0.39 Billion USD

According to BioCryst Pharmaceuticals 's latest financial reports the company has -$0.39 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BioCryst Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-$0.48 Billion4.48%
2023-12-31$-$0.46 Billion54.63%
2022-12-31$-$0.3 Billion175.36%
2021-12-31$-$0.11 Billion455.43%
2020-12-31$-$19.27 Million-150.36%
2019-12-31$$38.25 M-22.31%
2018-12-31$$49.23 M-41.22%
2017-12-31$$83.76 M5208.43%
2016-12-31$$1.57 M-96.69%
2015-12-31$$47.72 M-36.9%
2014-12-31$$75.63 M-6817.14%
2013-12-31$-$1.13 Million148.02%
2012-12-31$-$0.46 Million-103.07%
2011-12-31$$14.8 M-77.4%
2010-12-31$$65.5 M-24.07%
2009-12-31$$86.26 M85.81%
2008-12-31$$46.42 M-28.47%
2007-12-31$$64.9 M206.81%
2006-12-31$$21.15 M-63.8%
2005-12-31$$58.44 M99.22%
2004-12-31$$29.33 M3.12%
2003-12-31$$28.44 M-29.11%
2002-12-31$$40.12 M-29.37%
2001-12-31$$56.81 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Repligen
RGEN
$2.08 B-637.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$1.32 B-440.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
$7.51 M-101.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-$0.16 Billion-59.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$21.45 B-5,631.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$0.59 B-254.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$21.17 B-5,559.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
$0.58 B-250.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
$7.02 M-101.81%๐Ÿ‡บ๐Ÿ‡ธ USA